Thyroid No Surgery: Thyroid Nodules in One Lobe after Lobectomy Surgery. What Are You to Do? Another Surgery? No

Thyroid No Surgery: Thyroid Nodules in One Lobe after Lobectomy Surgery. What Are You to Do? Another Surgery? No

Thyroid No Surgery: Thyroid Nodules in One Lobe after Lobectomy Surgery. What Are You to Do? Another Surgery? No
Thyroid No Surgery: Thyroid Nodules in One Lobe after Lobectomy Surgery. What Are You to Do? Another Surgery? No
Read this article and you will want to refuse another surgery and travel to Europe or Korea for Radiofrequency Ablation.  This will preserve you remaining thyroid function compared to lifetime thyroid treatment after the second lobe is removed.
Call Matt for details on our referral system.310-393-8860

Radiofrequency Ablation of Benign Thyroid Nodules Does Not Affect Thyroid Function in Patients with Previous Lobectomy

Eun Ju Ha, Jung Hwan Baek, et al

Thyroid. March 2013, 23(3): 289-293.

ABSTRACT

Background: Surgical management of symptomatic benign thyroid nodules in patients with previous lobectomy poses a dilemma for physicians. Radiofrequency (RF) ablation may provide a treatment option that avoids surgery and preserves thyroid function. We evaluated whether RF ablation of benign thyroid nodules affects thyroid function in patients with previous lobectomy.

Methods: A total of 11 patients with 14 thyroid nodules were enrolled using the following criteria: (i) having a predominantly solid nodule; (ii) reporting pressure symptoms or cosmetic problems; (iii) cytological confirmation of benignancy; (iv) no malignant features detected using ultrasound; (v) serum thyroid hormone and thyrotropin (TSH) levels within normal limits; and (vi) refusal of or ineligibility for surgery. Thyroid function, nodule volumes, and clinical concerns were evaluated before RF ablation and during follow-up after RF ablation.

Results: The mean follow-up duration after RF ablation was 43.7±30.7 months (range=7–92 months). The mean nodule volume was 9.7 mL (0.9–57.6 mL) before the procedure, and was significantly decreased at the last follow-up (p<0.001) with a mean volume reduction rate of 87.2%. The mean symptom score (p=0.003) and cosmetic score (p=0.003) were both significantly decreased at the last follow-up. Levels of TSH, free thyroxine, and triiodothyronine were not significantly different prior to treatment and at the last follow-up (p>0.05), and remained normal in all patients.

 

Conclusions: In patients with previous lobectomy, RF ablation should be considered as a first-line treatment for symptomatic benign thyroid nodules to preserve thyroid function.

Add Your Comment

Contact Info
1328 16th Street, Santa Monica, CA 90404
Monday – Friday
9:00 AM to 5:00 PM
(310) 393-8860